17.0605.75% ( -1.040 )
Trading: Nov 16, 13:26:24 (EDT)Overview
City Therapeutics (CTY)
City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineering RNAi trigger molecu...
- Open
- 18.110
- High
- 18.110
- Low
- 16.760
- Prev. Close
- 18.100
- Volume
- 76.02K
- Turnover
- 1.31M
- Avg Price
- 17.247
- Bid/Ask Ratio
- 36.04%
- Amplitude
- 7.46%
- 52wk High
- 23.880
- Volume Ratio
- 1.85
- Turnover Ratio
- 0.32%
- 52wk Low
- 15.810
- Float Mkt Cap
- 411.15M
- Market CapUSD
- 848.85M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.76
- EPSDynamic
- -2.15
- EPSStatic
- --
- BVPS
- -2.65
- P/B
- --
- Circulating Supply
- 24.10M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 49.76M
- Min lot size
- 1
- Currency
- USD
City Therapeutics Analyst Rating
View moreForecast & Rating
Nov 10, 2026Price forecast
$37.33119.87%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 3
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
Market Movers · City Therapeutics tumbles 8% during regular trading
Market Movers · City Therapeutics surges 12% during regular trading
Market Movers · City Therapeutics climbs 9% during regular trading
Market Movers · City Therapeutics surges 8% during regular trading
Market Movers · City Therapeutics hits 52-week low
